{"id":"W4380154583","doi":"10.1016/j.jval.2023.03.1183","title":"HPR36 Utilization of Glucagon-like Peptide-1 Receptor Agonists in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Medicine; Diabetes mellitus; Receptor; Business; Internal medicine; Type 2 diabetes; Endocrinology; Economics; Agonist; Health care; Economic growth","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007326297,0.0002824372,0.0005514286,0.001873554,0.002477785,0.002171625,0.0009824267,0.0006210778,0.00664873],"category_scores_gemma":[0.002504856,0.0003908967,0.0008752959,0.005862406,0.0005478345,0.0003516459,0.0007884252,0.001248486,0.0004545669],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.07743228,"about_ca_system_score_gemma":0.1220835,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.9977078,"about_ca_topic_score_gemma":0.9985406,"domain_scores_codex":[0.9984242,0.000132202,0.0001195758,0.0001787852,0.0005668277,0.0005785159],"domain_scores_gemma":[0.995609,0.0002478641,0.0005612923,0.00005460014,0.001980815,0.001546385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001356913,0.000317636,0.847643,0.0007416367,0.0004140981,0.001417151,0.00238578,0.0009015907,0.001485038,0.004790077,0.04301495,0.09553209],"study_design_scores_gemma":[0.0001211012,0.000157432,0.9463444,0.0004973163,0.0002054332,0.0006356173,0.003967456,0.0009973849,0.0005060928,0.0002342517,0.04625171,0.00008169193],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8990192,0.01695747,0.0004652292,0.0155124,0.0003195301,0.0002079795,0.03267673,0.00009054214,0.03475093],"genre_scores_gemma":[0.9654487,0.01190832,0.0009629138,0.003407964,0.0000773978,0.00006209889,0.004268148,0.00006508461,0.01379929],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07743228,"threshold_uncertainty_score":0.5618131,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05849654635247051,"score_gpt":0.3034040961350724,"score_spread":0.2449075497826018,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}